194 related articles for article (PubMed ID: 27477687)
1. Design of a novel thiophene inhibitor of 15-lipoxygenase-1 with both anti-inflammatory and neuroprotective properties.
Eleftheriadis N; Poelman H; Leus NGJ; Honrath B; Neochoritis CG; Dolga A; Dömling A; Dekker FJ
Eur J Med Chem; 2016 Oct; 122():786-801. PubMed ID: 27477687
[TBL] [Abstract][Full Text] [Related]
2. Rational Development of a Potent 15-Lipoxygenase-1 Inhibitor with in Vitro and ex Vivo Anti-inflammatory Properties.
Eleftheriadis N; Neochoritis CG; Leus NG; van der Wouden PE; Dömling A; Dekker FJ
J Med Chem; 2015 Oct; 58(19):7850-62. PubMed ID: 26331552
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities.
Pontiki E; Hadjipavlou-Litina D; Litinas K; Nicolotti O; Carotti A
Eur J Med Chem; 2011 Jan; 46(1):191-200. PubMed ID: 21106277
[TBL] [Abstract][Full Text] [Related]
4. Anti-Cancer Activity of 2,4-Disubstituted Thiophene Derivatives: Dual Inhibitors of Lipoxygenase and Cyclooxygenase.
Rakesh KS; Jagadish S; Swaroop TR; Mohan CD; Ashwini N; Harsha KB; Zameer F; Girish KS; Rangappa KS
Med Chem; 2015; 11(5):462-72. PubMed ID: 25494807
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
[TBL] [Abstract][Full Text] [Related]
6. Development of 3,5-dinitrobenzoate-based 5-lipoxygenase inhibitors.
Shang E; Liu Y; Wu Y; Zhu W; He C; Lai L
Bioorg Med Chem; 2014 Apr; 22(8):2396-402. PubMed ID: 24685113
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of 12/15-Lipoxygenase Protects Against β-Cell Oxidative Stress and Glycemic Deterioration in Mouse Models of Type 1 Diabetes.
Hernandez-Perez M; Chopra G; Fine J; Conteh AM; Anderson RM; Linnemann AK; Benjamin C; Nelson JB; Benninger KS; Nadler JL; Maloney DJ; Tersey SA; Mirmira RG
Diabetes; 2017 Nov; 66(11):2875-2887. PubMed ID: 28842399
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and docking studies of 2,4,6-trihydroxy-3-geranylacetophenone analogs as potential lipoxygenase inhibitor.
Ng CH; Rullah K; Aluwi MF; Abas F; Lam KW; Ismail IS; Narayanaswamy R; Jamaludin F; Shaari K
Molecules; 2014 Aug; 19(8):11645-59. PubMed ID: 25100256
[TBL] [Abstract][Full Text] [Related]
9. Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors.
Eleftheriou P; Geronikaki A; Hadjipavlou-Litina D; Vicini P; Filz O; Filimonov D; Poroikov V; Chaudhaery SS; Roy KK; Saxena AK
Eur J Med Chem; 2012 Jan; 47(1):111-24. PubMed ID: 22119153
[TBL] [Abstract][Full Text] [Related]
10. 3,5-Disubstituted Isoxazole Derivatives: Potential Inhibitors of Inflammation and Cancer.
Rakesh KS; Jagadish S; Balaji KS; Zameer F; Swaroop TR; Mohan CD; Jayarama S; Rangappa KS
Inflammation; 2016 Feb; 39(1):269-280. PubMed ID: 26363638
[TBL] [Abstract][Full Text] [Related]
11. Elucidation of the molecular mechanism and the efficacy in vivo of a novel 1,4-benzoquinone that inhibits 5-lipoxygenase.
Schaible AM; Filosa R; Temml V; Krauth V; Matteis M; Peduto A; Bruno F; Luderer S; Roviezzo F; Di Mola A; de Rosa M; D'Agostino B; Weinigel C; Barz D; Koeberle A; Pergola C; Schuster D; Werz O
Br J Pharmacol; 2014 May; 171(9):2399-412. PubMed ID: 24467325
[TBL] [Abstract][Full Text] [Related]
12. A potent and selective inhibitor targeting human and murine 12/15-LOX.
Armstrong MM; Freedman CJ; Jung JE; Zheng Y; Kalyanaraman C; Jacobson MP; Simeonov A; Maloney DJ; van Leyen K; Jadhav A; Holman TR
Bioorg Med Chem; 2016 Mar; 24(6):1183-90. PubMed ID: 26899595
[TBL] [Abstract][Full Text] [Related]
13. New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study.
El-Miligy MMM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SAM
Bioorg Chem; 2017 Jun; 72():102-115. PubMed ID: 28390993
[TBL] [Abstract][Full Text] [Related]
14. Efficient synthesis and 5-LOX/COX-inhibitory activity of some 3-hydroxybenzo[b]thiophene-2-carboxylic acid derivatives.
Hansen FK; Khankischpur M; Tolaymat I; Mesaros R; Dannhardt G; Geffken D
Bioorg Med Chem Lett; 2012 Aug; 22(15):5031-4. PubMed ID: 22749420
[TBL] [Abstract][Full Text] [Related]
15. Discovery and Optimization of Indoline-Based Compounds as Dual 5-LOX/sEH Inhibitors:
Cerqua I; Musella S; Peltner LK; D'Avino D; Di Sarno V; Granato E; Vestuto V; Di Matteo R; Pace S; Ciaglia T; Bilancia R; Smaldone G; Di Matteo F; Di Micco S; Bifulco G; Pepe G; Basilicata MG; Rodriquez M; Gomez-Monterrey IM; Campiglia P; Ostacolo C; Roviezzo F; Werz O; Rossi A; Bertamino A
J Med Chem; 2022 Nov; 65(21):14456-14480. PubMed ID: 36318728
[TBL] [Abstract][Full Text] [Related]
16. Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities.
Ghatak S; Vyas A; Misra S; O'Brien P; Zambre A; Fresco VM; Markwald RR; Swamy KV; Afrasiabi Z; Choudhury A; Khetmalas M; Padhye S
Bioorg Med Chem Lett; 2014 Jan; 24(1):317-24. PubMed ID: 24295787
[TBL] [Abstract][Full Text] [Related]
17. Pyrazoles and Pyrazolines as Anti-Inflammatory Agents.
Mantzanidou M; Pontiki E; Hadjipavlou-Litina D
Molecules; 2021 Jun; 26(11):. PubMed ID: 34198914
[TBL] [Abstract][Full Text] [Related]
18. Pteridine-2,4-diamine derivatives as radical scavengers and inhibitors of lipoxygenase that can possess anti-inflammatory properties.
Pontiki E; Hadjipavlou-Litina D; Patsilinakos A; Tran TM; Marson CM
Future Med Chem; 2015; 7(14):1937-51. PubMed ID: 26423719
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and identification of novel substituted 2-amino thiazole analogues as potential anti-inflammatory agents targeting 5-lipoxygenase.
Sinha S; Doble M; Manju SL
Eur J Med Chem; 2018 Oct; 158():34-50. PubMed ID: 30199704
[TBL] [Abstract][Full Text] [Related]
20. Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR.
Meshram MA; Bhise UO; Makhal PN; Kaki VR
Eur J Med Chem; 2021 Dec; 225():113804. PubMed ID: 34479036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
